Loss of heterozygosity off the P16, P53 and APC gene in oral cavity exfoliate citologic material among lung cancer patients

被引：0
|
作者：
Ortega, JS
Esponera, JS
Hernandez, S
Saez, M
Roig, F
Muñoz, A
Callol, L
机构：
[1] CNIO, Hosp Clin Carlos, Madrid, Spain
[2] Hosp Gen Bas Defensa, Valencia, Spain
[3] Hosp Cent Defensa, Madrid, Spain
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [31] Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer
    Masayuki Sasaki
    Kenji Sugio
    Yasuo Juwabara
    Hirofumi Koga
    Makoto Nakagawa
    Tao Chen
    Koichiro Kaneko
    Kazutaka Hayashi
    Yoshiyuki Shioyama
    Shuji Sakai
    Hiroshi Honda
    Annals of Nuclear Medicine, 2003, 17 : 189 - 196
  • [32] Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer
    Sasaki, M
    Sugio, K
    Kuwabara, Y
    Koga, H
    Nakagawa, M
    Chen, T
    Kaneko, K
    Hayashi, K
    Shio-Yama, Y
    Sakai, S
    Honda, H
    ANNALS OF NUCLEAR MEDICINE, 2003, 17 (03) : 189 - 196
  • [33] Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations
    Havrilesky, LJ
    Alvarez, AA
    Whitaker, RS
    Marks, JR
    Berchuck, A
    GYNECOLOGIC ONCOLOGY, 2001, 83 (03) : 491 - 500
  • [34] Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, PRAD-1 and HPV
    Olshan, AF
    Weissler, MC
    Pei, H
    Conway, K
    Anderson, S
    Fried, DB
    Yarbrough, WG
    ONCOGENE, 1997, 14 (07) : 811 - 818
  • [35] Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV
    Andrew F Olshan
    Mark C Weissler
    Hong Pei
    Kathleen Conway
    Steven Anderson
    Daniel B Fried
    Wendell G Yarbrough
    Oncogene, 1997, 14 : 811 - 818
  • [36] Combine effect of P53 protein expression with P16 and P14 in survival outcome of breast cancer patients
    Pare, R.
    Shin, J. S.
    Lee, C. S.
    BREAST, 2017, 32 : S102 - S102
  • [37] LOSS OF HETEROZYGOSITY AFFECTING THE P53, RB, AND MCC/APC TUMOR SUPPRESSOR GENE LOCI IN DYSPLASTIC AND CANCEROUS ULCERATIVE-COLITIS
    GREENWALD, BD
    HARPAZ, N
    YIN, J
    HUANG, Y
    TONG, Y
    BROWN, VL
    MCDANIEL, T
    NEWKIRK, C
    RESAU, JH
    MELTZER, SJ
    CANCER RESEARCH, 1992, 52 (03) : 741 - 745
  • [38] New molecular approaches to lung cancer:: biological and clinical implications of P53, P16 and K-RAS studies
    Niklinska, W
    Chyczewski, L
    Niklinski, J
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 (02): : 99 - 103
  • [39] Polymorphism of the p53 gene within the codon 72 in lung cancer patients
    Biros, E
    Kalina, I
    Biros, I
    Kohüt, A
    Bogyiová, E
    Salagovic, J
    Stubña, J
    NEOPLASMA, 2001, 48 (05) : 407 - 411
  • [40] Loss of heterozygosity on chromosome 9p21 (p15, p16) and 17p13 (p53) in enteropathy-type T-cell lymphoma
    Obermann, EC
    Diss, TC
    Camozzi, MLP
    Hamoudi, RA
    Isaacson, PG
    Du, MQ
    Dogan, A
    MODERN PATHOLOGY, 2003, 16 (01) : 247A - 247A
12345